[go: up one dir, main page]

SE9702774D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9702774D0
SE9702774D0 SE9702774A SE9702774A SE9702774D0 SE 9702774 D0 SE9702774 D0 SE 9702774D0 SE 9702774 A SE9702774 A SE 9702774A SE 9702774 A SE9702774 A SE 9702774A SE 9702774 D0 SE9702774 D0 SE 9702774D0
Authority
SE
Sweden
Prior art keywords
pct
novel compounds
sec
date
compounds
Prior art date
Application number
SE9702774A
Other languages
English (en)
Swedish (sv)
Inventor
Roger Brown
Garry Pairaudeau
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9702774A priority Critical patent/SE9702774D0/xx
Publication of SE9702774D0 publication Critical patent/SE9702774D0/xx
Priority to IDW20000145D priority patent/ID25856A/id
Priority to SK1882-99A priority patent/SK188299A3/sk
Priority to JP2000504140A priority patent/JP2001510843A/ja
Priority to AT98934108T priority patent/ATE216390T1/de
Priority to IL13411198A priority patent/IL134111A0/xx
Priority to CA002296426A priority patent/CA2296426A1/fr
Priority to TR2000/00152T priority patent/TR200000152T2/xx
Priority to PL98338181A priority patent/PL338181A1/xx
Priority to HU0003826A priority patent/HUP0003826A3/hu
Priority to CN98809157A priority patent/CN1270591A/zh
Priority to AU83707/98A priority patent/AU8370798A/en
Priority to US09/155,567 priority patent/US6166022A/en
Priority to DE69804966T priority patent/DE69804966T2/de
Priority to KR1020007000653A priority patent/KR20010022084A/ko
Priority to PCT/SE1998/001394 priority patent/WO1999005144A1/fr
Priority to EP98934108A priority patent/EP0998475B1/fr
Priority to EEP200000048A priority patent/EE200000048A/xx
Priority to BR9811028-4A priority patent/BR9811028A/pt
Priority to IS5352A priority patent/IS5352A/is
Priority to NO20000313A priority patent/NO20000313L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
SE9702774A 1997-07-22 1997-07-22 Novel compounds SE9702774D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds
BR9811028-4A BR9811028A (pt) 1997-07-22 1998-07-15 Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um composto
PL98338181A PL338181A1 (en) 1997-07-22 1998-07-15 Novel chemical compounds
CN98809157A CN1270591A (zh) 1997-07-22 1998-07-15 新的化合物
JP2000504140A JP2001510843A (ja) 1997-07-22 1998-07-15 新規な化合物
AT98934108T ATE216390T1 (de) 1997-07-22 1998-07-15 Neue verbindungen
IL13411198A IL134111A0 (en) 1997-07-22 1998-07-15 Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation
CA002296426A CA2296426A1 (fr) 1997-07-22 1998-07-15 Nouveaux composes
TR2000/00152T TR200000152T2 (tr) 1997-07-22 1998-07-15 Yeni bileşikler.
IDW20000145D ID25856A (id) 1997-07-22 1998-07-15 Senyawa-senyawa baru
HU0003826A HUP0003826A3 (en) 1997-07-22 1998-07-15 Novel triazolo [4,5-b] pyrimidine derivatives, process for their preparation and pharmaceutical compositions thereof
SK1882-99A SK188299A3 (en) 1997-07-22 1998-07-15 Triazolo [4,5-d]pyrimidine compounds, preparation thereof, pharmaceutical compositions containing them and their use
AU83707/98A AU8370798A (en) 1997-07-22 1998-07-15 Novel compounds
US09/155,567 US6166022A (en) 1997-07-22 1998-07-15 Compounds
DE69804966T DE69804966T2 (de) 1997-07-22 1998-07-15 Neue verbindungen
KR1020007000653A KR20010022084A (ko) 1997-07-22 1998-07-15 신규한 화합물
PCT/SE1998/001394 WO1999005144A1 (fr) 1997-07-22 1998-07-15 Nouveaux composes
EP98934108A EP0998475B1 (fr) 1997-07-22 1998-07-15 Nouveaux composes
EEP200000048A EE200000048A (et) 1997-07-22 1998-07-15 Uudsed ühendid
IS5352A IS5352A (is) 1997-07-22 2000-01-19 Ný efnasambönd
NO20000313A NO20000313L (no) 1997-07-22 2000-01-21 Nye forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds

Publications (1)

Publication Number Publication Date
SE9702774D0 true SE9702774D0 (sv) 1997-07-22

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds

Country Status (21)

Country Link
US (1) US6166022A (fr)
EP (1) EP0998475B1 (fr)
JP (1) JP2001510843A (fr)
KR (1) KR20010022084A (fr)
CN (1) CN1270591A (fr)
AT (1) ATE216390T1 (fr)
AU (1) AU8370798A (fr)
BR (1) BR9811028A (fr)
CA (1) CA2296426A1 (fr)
DE (1) DE69804966T2 (fr)
EE (1) EE200000048A (fr)
HU (1) HUP0003826A3 (fr)
ID (1) ID25856A (fr)
IL (1) IL134111A0 (fr)
IS (1) IS5352A (fr)
NO (1) NO20000313L (fr)
PL (1) PL338181A1 (fr)
SE (1) SE9702774D0 (fr)
SK (1) SK188299A3 (fr)
TR (1) TR200000152T2 (fr)
WO (1) WO1999005144A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
DE69905451T2 (de) * 1998-02-17 2003-11-20 Astrazeneca Uk Ltd., London Neue triazolo(4,5d) pyrimidinverbindungen
CA2380656A1 (fr) * 1999-09-09 2001-03-15 Nadine Derrien Cyclopentenes substitues, leur preparation et leur utilisation pour des ossatures chirales
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7435724B2 (en) 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
US7294635B2 (en) 2003-10-03 2007-11-13 Portola Pharmaceuticals, Inc. Substituted isoquinolinones
AU2004278030C1 (en) 2003-10-03 2010-12-02 Portola Pharmaceuticals, Inc. 2,4-Dioxo-3-quinazolinylaryl sulfonylureas
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
EP1685135B1 (fr) 2003-10-21 2010-05-26 Inspire Pharmaceuticals, Inc. COMPOSES TETRAHYDRO-FURO[3,4-d]DIOXOLE, ET COMPOSITIONS ET PROCEDE POUR INHIBER UNE AGREGATION PLAQUETTAIRE
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
BRPI0516181A (pt) 2004-09-29 2008-08-26 Portola Pharm Inc composto e sais farmaceuticamente aceitáveis do mesmo, composição farmacêutica, e, métodos para tratar trombose em um indivìduo e para prevenir a ocorrência de um evento isquêmico secundário
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
WO2007020935A1 (fr) * 2005-08-17 2007-02-22 Ono Pharmaceutical Co., Ltd. Agent thérapeutique pour soulager la douleur, comprenant un récepteur p2y12 et/ou un bloqueur de récepteur p2y14
KR101423483B1 (ko) 2005-11-03 2014-07-28 포톨라 파마슈티컬스, 인코포레이티드 〔４-(６-할로-７-치환된-２,４-디옥소-１,４-디히드로-２ｈ-퀴나졸린-３-일)-페닐〕-５-클로로티오펜-２-일-설포닐우레아 및 이의 형태 및 이와 관련된 방법
WO2008054795A2 (fr) * 2006-10-31 2008-05-08 Janssen Pharmaceutica, N.V. Dérivés de triazolopyrimidine convenant comme antagonistes du récepteur p2y12 de l'adp
US9725479B2 (en) 2010-04-22 2017-08-08 Ionis Pharmaceuticals, Inc. 5′-end derivatives
WO2011150205A2 (fr) * 2010-05-27 2011-12-01 Dr. Reddy's Laboratories Ltd. Hydroformylation asymétrique extrêmement sélective de la (+) ou (-)-lactame (1s,4r)- ou (1r,4s)-2-azabicyclo[2.2.1]hept-5-én-3-one
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
US5506347A (en) * 1993-02-03 1996-04-09 Gensia, Inc. Lyxofuranosyl analogues of adenosine
EP0840740B1 (fr) * 1995-07-11 2002-05-02 AstraZeneca AB Nouveaux inhibiteurs de l'agregation plaquettaire

Also Published As

Publication number Publication date
IL134111A0 (en) 2001-04-30
BR9811028A (pt) 2000-08-01
EP0998475B1 (fr) 2002-04-17
NO20000313D0 (no) 2000-01-21
ATE216390T1 (de) 2002-05-15
HUP0003826A3 (en) 2001-11-28
NO20000313L (no) 2000-03-22
WO1999005144A1 (fr) 1999-02-04
EE200000048A (et) 2000-10-16
SK188299A3 (en) 2000-08-14
EP0998475A1 (fr) 2000-05-10
PL338181A1 (en) 2000-10-09
ID25856A (id) 2000-11-09
HUP0003826A2 (hu) 2001-04-28
IS5352A (is) 2000-01-19
CA2296426A1 (fr) 1999-02-04
DE69804966D1 (de) 2002-05-23
KR20010022084A (ko) 2001-03-15
CN1270591A (zh) 2000-10-18
TR200000152T2 (tr) 2000-07-21
JP2001510843A (ja) 2001-08-07
DE69804966T2 (de) 2002-11-07
US6166022A (en) 2000-12-26
AU8370798A (en) 1999-02-16

Similar Documents

Publication Publication Date Title
SE9702774D0 (sv) Novel compounds
SE9702772D0 (sv) Novel compounds
TR200000197T2 (tr) Yeni bileşimler
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
YU40300A (sh) Aril fuzirana azapoliciklična jedinjenja
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
ATE212993T1 (de) Pyrolopyrimidine und verfahren zu ihrer herstellung
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
SE9702564D0 (sv) New compounds
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
SE9702563D0 (sv) Compounds
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
NO970473L (no) N-substituerte 3-azabicyklo (3.2.0)heptanderivater egnet som neuroleptika
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
MX9603199A (es) Antagonistas de receptores a endotelina.
BG101328A (en) New derivatives of imidazoloquinaxalon with heterocyclic substituents, their preparation and use
SE0004099D0 (sv) Novel compounds
MY136138A (en) Hexacyclic compounds
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use